(Q40342329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Talia Golan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Tal Sella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Matthew H G Katz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Ron Epelbaum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

David P Kelsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Ayelet Borgida

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Hannah Maynard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Hedy Kindler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Eitan Friedmen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Milind Javle

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

9 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

697-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

2 April 2020

copyright license

start time

9 February 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Improvement of surgical results for pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Subtyping Pancreatic Cancer.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355924

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2017.19

Vascular resection in pancreatic cancer surgery: survival determinants

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2017.19

inferred from DOI database lookup

7 January 2021

based on heuristic

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2017.19

inferred from DOI database lookup

7 January 2021

based on heuristic

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28183138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2017.19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28183138%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

PubMed publication ID

28183138

1 reference